Frontier Wealth Management LLC Jounce Therapeutics, Inc. Transaction History

Frontier Wealth Management LLC

  • $8.02 Billion
  • Q2 2022

A detailed history of Frontier Wealth Management LLC transactions in Jounce Therapeutics, Inc. stock. As of the latest transaction made, Frontier Wealth Management LLC holds 13,099 shares of JNCE stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,099
Previous 13,099 -0.0%
Holding current value
$0
Previous $87,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$6.73 - $13.87 $94,220 - $194,180
-14,000 Reduced 51.66%
13,099 $135,000
Q1 2018

May 15, 2018
BUY
$13.4 - $28.4 $363,126 - $769,611
27,099 New
27,099 $606,000

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Frontier Wealth Management LLC Portfolio

Follow Frontier Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email